How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

The frontier model is a commodity. The companies winning are the ones that own distribution, and venture capital is paying up ...

Building a model capable of RSI would require automating a range of specialist tasks currently carried out by humans. At present data scientists work on the theory of AI and coders put it into ...

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...

The AWS SDK for JavaScript v3 is a rewrite of v2 with some great new features. As with version 2, it enables you to easily work with Amazon Web Services, but has a modular architecture with a separate ...

Abstract: Return-oriented programming (ROP) attacks pose a significant threat to the control-flow integrity (CFI) of Internet of Things (IoT) devices, which operate in resource-constrained ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

In Meta's Q1 earnings call, Barclays analyst Ross Sandler asked Zuckerberg about the company's strategy for AI coding and "the recursive self-improvement loop." Zuckerberg replied that he thinks that ...

In the last few years, Chinese AI startup MiniMax has become one of the most exciting in the crowded global AI marketplace, carving out a reputation for delivering frontier-level large language models ...

SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...